German industrial group Siemens AG has entered into a partnership with Tsinghua University, one of Siemens' center of kn...
Eight Roads Ventures, the proprietary investment arm of Fidelity International Ltd, has launched its first dedicated Chi...
Magnetic nanoparticle clusters have the power to punch through biofilms to reach bacteria that can foul water treatment ...
Columbia China, a 50-50 joint venture between Seattle’s Columbia Pacific Management and Singapore investment compa...
In a bid to bring operational efficiency and improve data management, Chinese healthcare group Fosun Pharma has ad...
Cambricon, an artificial intelligence (AI) chipmaker based in China, has raised $100 million in series A funding led by ...
Swedish drug giant Medivir recently announced that it has offloaded its exclusive rights to develop, manufacture and com...
Visiting Chinese Vice-Premier, Wang Yang, on Wednesday pledged full support to Nepal for the development and promotion o...
Ankon Technologies Co., Ltd., a U.S. and China-based company developing medical equipment for gastric diagnosis, has rai...
To cater to the increasing demand for exclusive health care services among the Chinese high net-worth, Vista, a veteran ...
Chinese pharma giant Shanghai pharma has inked a deal with contract logistics firm DHL Supply Chain to prepare its logis...
According to reports, GSK China has planned to pull down shutters on its neuroscience R&D center located in Shanghai...
WuXi AppTec, the leading global pharmaceutical and biopharmaceutical open access capability platform has ...
Dedicated to developing global antibody and recombinant protein bio-therapeutics, Hangzhou Just Biotherapeutics, Ltd. (J...
If reports are to be believed, India is all set to block China’s Fosun Pharmaceutical Group’s proposed $1.3-...
iKang Healthcare Group, Inc., a major provider in China’s fast growing private preventive healthcare services mark...
C-Bridge Capital, a Chinese private equity firm targeting the healthcare sector, has closed its second fund, C-Bridge He...
Bionic ear implant maker Cochlear is expanding its global manufacturing capacity with a new $50 million facility in Chin...
In a new collaboration, ShangPharma Innovation, Inc. (SPII) is providing funding and other support to scientists at UC S...
Trovagene, Inc. has entered into an agreement with Novogene Co. Ltd., a leading global provider of genomic services and ...
Shanghai Fosun Pharmaceutical (Group) Co. will spend $73.5 million to set up a technology innovation incubator which wil...
The National Clinical Research Center for Cancer (NCRCC) in China has signed a deal with the Institute of Computing Tech...
Zai Lab Limited, a Shanghai-based innovative biopharmaceutical company has raised $30 million in a Series C preferred eq...
Vivace Therapeutics, an oncology-focused portfolio-based drug discovery and development company is has raised $40 millio...
iCarbonX, a Chinese health-related data mining and analysis firm, has joined a $8.4 million Series B financing round in ...
